American Regent, Inc.: Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vial
Read the official notice at FDA (drug) →
Get alerts for American Regent
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- American Regent, Inc.
- Product
- Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
- Reason / hazard
- Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
- Classification
- Class I
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the U.S
- Recall initiated
- 2026-07-24
- Code info
- Lot #: 25202, Exp. Date: 11/30/2026.
- Product quantity
- 86,100 vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Shirley
- State
- NY
- Country
- United States
- Event id
- 99503
Free daily digest + "My products" watchlist